Last reviewed · How we verify

NCT03567590

The Efficacy and Safety of Sphenopalatine Ganglion Pulsed Radiofrequency Treatment for Cluster Headache

Completed NA Last updated 26 October 2021
What this trial tests

NA trial testing Pulsed Radiofrequency treatment in Cluster Headache in 80 participants. Completed in 5 January 2021.

Timeline
5 July 2018
Primary endpoint
24 April 2020
5 January 2021

Quick facts

Lead sponsorBeijing Tiantan Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment80
Start date5 July 2018
Primary completion24 April 2020
Estimated completion5 January 2021
Sites3 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Beijing Tiantan Hospital

Who can join

Adults 18 to 60, any sex, with Cluster Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aim to investigate the effectiveness and safety of sphenopalatine ganglion pulsed radiofrequency on cluster headache.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cluster Headache

Currently open trials in the same condition.

Other Beijing Tiantan Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03567590.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing